NYLIM
HALO icon

New York Life Investment Management’s Halozyme HALO Stock Holding History

New York Life Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
17,242
+683
+4% +$46.6K 0.01% 631
2026
Q1 		$1.07M Buy
16,559
+5,798
+54% +$409K 0.01% 655
2025
Q4 		$724K Sell
10,761
-1,730
-14% -$116K 0.01% 670
2025
Q3 		$916K Sell
12,491
-353
-3% -$23.4K 0.01% 675
2025
Q2 		$668K Sell
12,844
-700
-5% -$39.8K 0.01% 722
2025
Q1 		$864K Buy
13,544
+184
+1% +$10.7K 0.01% 673
2024
Q4 		$639K Sell
13,360
-2,706
-17% -$139K 0.01% 756
2024
Q3 		$920K Buy
+16,066
New +$921K 0.01% 712

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

New York Life Investment Management's HALO Position: Q2 2026 in Review

New York Life Investment Management increased its Halozyme (HALO) stake by 4.1% in Q2 2026, buying an estimated $46.6K and bringing the position to 17,242 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #631.

New York Life Investment Management first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. 491 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • New York Life Investment Management held 17,242 shares of Halozyme worth $1.35M as of Q2 2026.
  • New York Life Investment Management bought 683 Halozyme shares in Q2 2026, an estimated $46.6K.
  • Halozyme made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #631 holding.
  • New York Life Investment Management first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
  • 491 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.